Pharmaceutical News and Articles

Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma

For patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall

Vigorous Physical Activity May Preserve Cognitive Function in High-Risk HTN

For high-risk patients with hypertension, vigorous physical activity (VPA) may preserve cognitive function, according to a study published online June 6 in Alzh

Aerobic Exercise Tied to Improved Clinical Asthma Outcomes

Moderate- and vigorous-intensity aerobic exercise training are associated with improvements in clinical asthma outcomes, according to a study published online J

Smartwatch, Smartphone Can Assess Parkinson Disease Progression

Gait and tremor measures derived from a commercially available smartwatch and smartphone could help evaluate the efficacy of therapies for Parkinson disease (PD

Acupuncture Reduces Endocrine Symptoms, Hot Flashes in Breast Cancer

A 10-week acupuncture intervention significant reduces endocrine symptoms and hot flashes among women with breast cancer receiving endocrine therapy (ET), accor

U.S. Supreme Court Agrees to Hear Case on Medical Care for Transgender Youth

The U.S. Supreme Court announced Monday that it would hear a case on a Tennessee law that bans transgender minors from receiving certain medical treatments in t

Older Americans in Senior Housing Have Better Health Than Those Living at Home

Independent living is important for seniors, but a new study shows it might not be the best thing for their health.Older adults living in senior housing tended

Inhaled Insulin Could Help Folks With Type 1 Diabetes Avoid Needles

Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows.Patients using inhaled insu

Twice-a-Year Injection Gives Women Full Protection Against HIV, Trial Finds

an injection just twice a year is the option that could keep her free of HIV, Lillian Mworeko, who leads a group called the International Community of Women Liv

Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of Krazati (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)